Video & Transcript : 'drug scheduling' :

Page 28 of 500
AR

Arkansas 2026 Regular Session

ALC-GAME & FISH/STATE POLICE Jun 18th, 2026

ALC-GAME & FISH/STATE POLICE

Transcript Highlights:
  • So everything's been on schedule and going well there.
  • The new drug, is it cyclophene?
  • If you can speak more about how aggressive this drug is, and if we're seeing other counterfeit drugs
  • And we're talking grains of these drugs.
  • And so the drug director has been great in helping with that.
Keywords: 1204, all
TX
Transcript Highlights:
  • What's a Schedule A employee?
  • compared to Schedule B and C with the salary.
  • have to get there's three basic schedules schedule a Schedule A is your administrative.
  • Schedule B is your directors, professionals of that nature. Schedule C is your patrol.
  • Vendor Drug Rebates.
Bills: SB1 , SB 1
Committee: Senate Finance
NM

New Mexico 2025 Regular Session

IC - Courts, Corrections and Justice Jun 30th, 2025

Courts, Corrections & Justice Committee

Transcript Highlights:
  • Housing, um, street crime, homelessness, um, drug abuse.
  • Chairman, last cabinet, I know I'm on a time schedule.
  • They're they're going to be continuing to use drugs.
  • Drugs, we blame it on poverty. El Paso's across the street from the border.
  • The, the schedule shows us for a lunch break.
AR

Arkansas 2026 Regular Session

ALC-GAME & FISH/STATE POLICE Jun 18th, 2026

ALC-GAME & FISH/STATE POLICE

Transcript Highlights:
  • So everything's been on schedule and going well there.
  • The new drug, is it cyclophene?
  • “If you can speak more about how aggressive this drug is, and if we’re seeing other counterfeit drugs
  • And so the drug director has been great in helping with that.”
  • And so the drug director has been great in helping with that.
Summary: The committee met with representatives from the Arkansas State Crime Lab for an update on operations, staffing, technology, and major projects. Crime lab officials said the new facility is on schedule and under budget, with completion expected at the end of July next year and phased move-in beginning around August 1. They described the current building as overcrowded and outdated, and said the new lab will expand workspace, improve workflow, double morgue autopsy tables, and allow new technologies such as 3D firearms microscopy, improved drug testing for emerging synthetic drugs, and enhanced fingerprint visualization. Officials also said the lab has been able to hire positions tied to the 2023 overdose-autopsy law and that recruitment for medical examiners and fellows has improved, including two new medical examiners starting in August and a successful new fellowship program. Members asked about rapid DNA, CODIS, forensic genealogy, sexual assault kit backlogs, and staffing. The lab said rapid DNA is in final testing with Faulkner and Saline counties and could go live by the end of July, which would make Arkansas one of the first states to do so. Officials explained that CODIS is used routinely, with DNA profiles from qualifying cases uploaded automatically and audited regularly, and cited it as a key investigative tool. On forensic genealogy, they said Arkansas currently relies on private labs such as Othram, Bode, and DNA Labs International, and is exploring whether to bring that capability in-house in the future. They reported that the sexual assault kit backlog from around 2016 has been cleared and that the lab is now meeting the statutory 60-day turnaround time, with kits tracked through a barcode-based system for transparency. The committee also discussed overdose data and confidentiality. The lab said a new overdose dashboard is being developed with the Office of State Technology and should go live by the end of the year, using newly available reporting data to help public health and law enforcement target prevention efforts. Members praised a recent law allowing toxicology information to be shared with the state drug director and another law protecting coroner records and toxicology reports from public release during criminal investigations; lab officials said both changes have been very helpful. The meeting ended with no votes or formal actions on the crime lab items, and the chair announced an August site visit to the Lake Conway dam project.
WY

Wyoming 2026 Regular Session

House Judiciary Committee, February 25, 2026

Judiciary

Transcript Highlights:
  • </c> schedule just a little bit this morning. schedule just a little bit this morning.
  • can talk more about this, but they're looking at scheduling that substance as Schedule I.
  • can talk more about this, but they're looking at scheduling that substance as Schedule I.
  • </c> better than I can that our uh this drug better than I can that our uh this drug is<00:48:37.280>
  • </c> currently scheduled under federal law. currently scheduled under federal law.
Bills: SF0071 , SF0088 , SF0056
Committee: House Judiciary
KY

Kentucky 2026 Regular Session

Interim Joint Committee on Judiciary (6-9-26)

Judiciary

Transcript Highlights:
  • c> crisis</c><00:08:24.160><c> and</c> Two, combating the drug crisis and Two, combating the drug crisis
  • </c> Kucky's first ever statewide youth drug Kucky's first ever statewide youth drug prevention<00:26
  • </c> Uh we talk about dangerous drugs uh too. Uh we talk about dangerous drugs uh too.
  • </c> drug arrest so far. drug arrest so far.
  • </c> illegal drugs. illegal drugs.
Committee: Joint Judiciary
FL

Florida 2026 Regular Session

Criminal Justice Jan 12th, 2026

Criminal Justice

Transcript Highlights:
  • This includes drug treatment, getting and holding a job, medical care, restitution, and fulfilling family
  • drug product approved by the United States Food and Drug Administration for veterinary purposes.
  • The bill amends section 893.03 to accept from the list of Schedule 1 controlled substances.
  • Zylazine animal drug to accept from the list of Schedule 1 controlled substances.
  • Zylazine animal drug product approved by the United States Food and Drug Administration for veterinary
Keywords: 999, senate, all
CA
Transcript Highlights:
  • Drugs that are unsafe.
  • normal drug ads do.
  • We do not mass-market brand-name drugs.
  • Compounded drugs are not FDA-approved.
  • In this drug, it may cause certain things.
Summary: The committee heard several bills, beginning with AB 1921 on video game shutdowns. The author and Consumer Reports supported requiring game operators to give 60 days’ notice before ending server support and to offer a menu of remedies, including refunds or playable/offline alternatives, while the Entertainment Software Association opposed the bill as an unwarranted new standard for digital products and raised safety and legal concerns about community servers. Members questioned the scope of refunds, copyright, and community-server issues, and the author said he was open to further amendments. The bill was moved on a due-pass motion to Senate Appropriations and placed on call. AB 1965, dealing with cannabis testing, was presented as a measure to strengthen the Department of Cannabis Control’s authority over testing labs and improve product safety and transparency. The California Cannabis Operators Association supported the bill, saying it would help ensure consistent standards and protect consumers in a market with a large illicit component. There was no opposition, and the bill was moved on a due-pass motion to Senate Appropriations and placed on call. The committee also heard AB 2141, which would allow the Board of Pharmacy to resolve certain disciplinary matters through a voluntary pre-accusation settlement process. The author and a supporting pharmacist said it would speed resolution of smaller, technical cases and reduce costs, while a member raised concerns about transparency and whether the public would have less information about licensee misconduct. The bill passed the committee on a due-pass motion to Senate Appropriations, with Senator Menjivar voting no, and was placed on call. AB 2163, creating strategic clean energy and critical mineral development zones, was supported by the author and Imperial County as a way to prioritize geothermal and lithium development in areas like the Salton Sea region; it passed on a due-pass motion to Senate Appropriations and was placed on call. Later, AB 1990 on compounded weight-loss drug advertising drew significant debate. Supporters argued it would curb misleading ads and require disclosures about risks and non-FDA approval, while opponents from the compounding pharmacy community said it would create burdens, duplicate existing false-advertising law, and could harm patient access. Members questioned whether the bill actually addressed targeting minors and whether it would force use of FDA-approved labeling; the author said the bill was meant to add specificity and guardrails. The bill was moved on a due-pass motion to Senate Judiciary, with some no votes, and placed on call. The committee also heard AB 2783 on court reporters, which would add a national certification pathway and extend a remote reporting pilot; it drew support from court reporting stakeholders and passed unanimously on a due-pass motion to Senate Appropriations, placed on call. Finally, AB 2771, the Bureau for Private Postsecondary Education sunset bill, and AB 2772, the interior design certification sunset bill, were presented and heard with mixed testimony: AB 2771 received support from student and borrower advocates and was moved to Senate Education, while AB 2772 drew both support and strong opposition over CCIDC governance and accountability, with the committee hearing extensive public comment before the transcript ended.
HI
Transcript Highlights:
  • She explained that this is the annual bill presented to the Legislature to update and harmonize drug
  • laws with federal drug law changes made because of new and emerging drugs.
  • law, misspelled one of the very long scientific names for a drug.
  • She said they in turn followed and passed a law scheduling a substance with that incorrectly spelled
  • we in turn followed and um pass a drug we in turn followed and um pass a law<00:10:55.800><c> scheduling
Keywords: 912, senate, all
Summary: The Senate Committee on Public Safety and Military Affairs met on its 3:15 p.m. reconsideration and hearing agenda. The committee first reconsidered SB 1379 on emergency preparedness and voted to pass it with amendments. The amendments would require HEMA to submit a report to the Legislature on a community readiness centers plan, including public and private sites, funding sources, partnerships, stakeholder coordination, and projected annual funding, due 20 days before the 2026 Legislature convenes. The committee also made technical and fiscal-related changes, including blanking out certain amounts in the bill and committee report while retaining recommended amounts there, and changing the effective date language. The committee then voted unanimously to adopt the amended recommendation. The committee heard SB 1364, which makes emergency appropriations for law enforcement personnel costs. The Department of Budget and Finance supported the bill but said the figures in oral testimony would be slightly higher than those in written testimony and that updated numbers would be emailed later in the week. Because the exact figures were not yet available, the chair deferred decision-making to February 7, 2025. The committee also heard SB 1451 on critical infrastructure, SB 1452 on the Uniform Controlled Substances Act, SB 1149 on hate crimes reporting, SB 1321 on the Hawaii Correctional System Oversight Commission, and SB 1341 on energy industry information reporting. For SB 1451, testimony was split, with support from state law enforcement and opposition from the Public First Law Center, which argued the information was already protected under existing law; the committee later adopted a motion to pass the bill with amendments, including a narrower definition of critical infrastructure information and a revised effective date. SB 1452 received support from law enforcement and prosecutors, with a requested cleanup amendment to correct a federal drug-name spelling issue; decision-making was postponed to allow the department to provide language. SB 1149 drew substantial testimony both for and against; supporters emphasized better hate-crime data collection and transparency, while opponents raised concerns about definitions and free speech. The committee adopted amendments and passed the bill, with the chair summarizing the move from the older UCR system to NIBRS and noting a public dashboard expected by September 30, 2025. SB 1321 was passed with amendments shortening the oversight coordinator term from four years to three years, though one senator voted with reservations in favor of a longer term. SB 1341 was passed as is after brief support testimony, and the committee adjourned after completing the agenda.
CA

California 2025-2026 Regular Session

Assembly Health Committee Apr 22nd, 2025

Transcript Highlights:
  • Chine on behalf of Drug Policy Alliance in support.
  • Glenn Backus, for Drug Policy Alliance, in support.
  • drug manufacturers to participate in.
  • ICE. 340B drugs at one in-house pharmacy.
  • Second, PBMs obtain rebates from drug companies in return for having their drugs on the formulary.
Summary: The Assembly Health Committee met on April 22 and took up a special order of bills focused largely on prior authorization and utilization management in health care. The chair framed the discussion as part of a broader legislative effort to reduce delays and barriers to care, especially in behavioral health, chronic disease management, cancer treatment, and rehabilitation services. AB 384 by Assembly Member Connolly would prohibit prior authorization for inpatient mental health or substance use emergency admissions and related physician care; supporters said it would prevent dangerous delays in crisis care, while insurers and health plans warned about fraud, abuse, and ambiguity around residential treatment facilities. The bill was moved on a due pass as amended motion and passed the committee on a party-line style vote, with Republicans largely absent or not voting. The committee then heard AB 510 by Assembly Member Addis, which would require health plans, upon request, to provide a peer reviewer of the same or similar specialty when a treating provider appeals a prior authorization denial or modification. Supporters argued that specialty-matched review would make appeals fairer and more clinically informed; opponents said the requirement was too rigid and that timelines and electronic submission rules needed changes. After discussion about the need for timely, specialty-specific review, the bill was approved on a due pass as amended motion and placed on call. AB 539 by Assembly Member Schiavo would extend prior authorization approvals to one year or the duration of the physician’s prescribed treatment for chronic conditions; supporters cited repeated denials and treatment interruptions, while opponents raised concerns about overbreadth, fraud, and the need for shorter validity periods. The bill was also passed as amended and placed on call. The committee next considered AB 669 by Assembly Member Haney, which would bar concurrent and retrospective review for the first 28 days of medically necessary substance use disorder treatment and limit prior authorization for related outpatient medications. The bill was presented with a powerful personal story from Ryan Matlock’s mother about her son’s death after an insurer cut off treatment early; supporters said the measure would keep patients in care long enough to stabilize, while opponents argued it would reduce oversight and could allow lower-quality or non-evidence-based care. The bill was moved on a due pass as amended motion and placed on call. Finally, AB 512 by Assembly Member Harabedian would shorten prior authorization response times to 24 hours for urgent requests and 48 hours for non-urgent requests; supporters said delays can worsen outcomes, while opponents warned the timelines were unrealistic and could increase administrative burdens and safety issues. The bill was approved as amended and placed on call. AB 574 by Assembly Member Mark Gonzalez was then heard; it would allow up to 12 medically necessary physical therapy sessions for a new episode of care without prior authorization, with supporters emphasizing stroke and neurological recovery and opponents warning of reduced oversight and unnecessary care. The transcript ends during testimony on AB 574, before final action is shown.
MO

Missouri 2026 Regular Session

Joint Committee on Administrative Rules Jun 12th, 2026

Joint Committee on Administrative Rules

Transcript Highlights:
  • I'm the executive director for the Missouri Prescription Drug Monitoring Program.
  • Missouri PDMP only collects information, dispensation information on prescriptions for Schedule 2, Schedule
  • 3, and Schedule 4 medications.
  • In 2025, there were over 9 million Schedule 2, Schedule 3, or Schedule 4 prescriptions, with dispensation
  • All right. we may say schedule an appointment for next week.
Summary: The Joint Committee on Administrative Rules met with a quorum and approved the minutes from the prior meeting. Members announced that two Department of Natural Resources rules had been withdrawn, leaving only the Missouri Prescription Drug Monitoring Program (PDMP) rule proposal for consideration. Public testimony focused on a proposed expansion of PDMP access to additional licensed behavioral health professionals, including licensed clinical social workers, licensed master social workers, marriage and family therapists, professional counselors, and psychologists, along with related clarifications to delegate access categories such as medical assistants and clinical nurse specialists. Testimony from the PDMP director and supporters from Compass Health and the Department of Mental Health argued the changes would improve care coordination, medication reconciliation, and overdose prevention within multidisciplinary behavioral health teams, especially in CCBHC settings. They said access would remain limited to licensed Missouri professionals working under supervision or collaboration with a prescriber or dispenser, and that the system is intended for treatment-related, view-only use. Opponents and skeptical committee members raised concerns that the rule would expand access beyond the original statutory framework without legislative change, could create privacy risks or misuse in non-treatment contexts such as custody disputes, and might exceed the committee’s rulemaking authority. One public witness opposed the rule, warning it could deter patients from seeking counseling and arguing the change should be made, if at all, by statute. After testimony, committee members debated whether the proposal was a permissible clarification or an impermissible substantive expansion of the law. Supporters of disapproval said the issue was legality, not the merits of PDMP access, and urged the department to seek a bill sponsor if it wanted the change enacted. A motion was made and seconded to disapprove Rule 1 CSR 60-1.010 on the grounds of lack of statutory authority, conflict with state law, and arbitrariness/capriciousness. The committee then took a roll-call vote and approved the motion by 7 ayes to 1 no, disapproving the rule and adjourning with no further business.
NH

New Hampshire 2025 Regular Session

Senate Finance Budget Briefing (06/10/2025)

Transcript Highlights:
  • Schedule two adjustments.
  • Uh, Schedule 4 adjustments.
  • Uh schedule four adjustments. estimates. Uh schedule four adjustments.
  • </c> up on the surplus statement as schedule up on the surplus statement as schedule 2.<01:20:46.719>
  • </c> to repeal the prescription drug to repeal the prescription drug affordability<01:24:00.480><c> board
Keywords: 1191, senate, all
Summary: The Legislative Budget Assistant staff presented an overview of the Senate changes to the House-passed budget, focusing on revenue estimates, appropriations, and ending balances across the general fund and education trust fund. The presentation emphasized that the Senate’s budget reflected higher revenue assumptions than the House, driven in part by updated April revenue figures, changes to business, tobacco, and real estate transfer tax splits, and different assumptions about video lottery terminal revenue. The Senate also adjusted lapse estimates upward, especially for HHS, after receiving updated information that lapses could be much larger than originally assumed. The presenter walked through the major differences in the surplus statements for fiscal years 2025 through 2027. Compared with the House, the Senate budget generally showed higher revenues, lower or different appropriations in some areas, and larger balances carried forward, including a larger education trust fund balance and a different rainy day fund transfer. The Senate’s approach also changed several policy assumptions, such as maintaining liquor revenue dedication, removing the House’s meals-and-rooms distribution cap, changing the treatment of unique revenue, and altering the process for meeting a targeted revenue amount by giving the governor more flexibility. On the appropriations side, the Senate removed or modified several House reductions and added funding or adjustments in areas including the judicial branch, corrections, HHS, the Human Rights Commission, and certain settlement costs. The presenter also highlighted Senate changes in House Bill 2 and related budget provisions, including a new arts tax credit, a nursing home bed fee, changes to Medicaid premium assumptions, and differences in how motor vehicle inspection repeal and BLT-related revenue are handled. No votes were taken in the portion shown; the discussion was informational and comparative, aimed at explaining the Senate budget changes before conference committee negotiations.
NM
Transcript Highlights:
  • So House Bill 249 will be scheduled at a later date.
  • This reimbursement rate is $13,892 according to the Medicaid fee schedule.
  • According to the Medicaid fee schedule, effective date was 1 January 2015.
  • In our FIR, it says that they are reimbursed at 100% of the Medicare fee schedule.
  • Actually, Representative, we are paying 150% of the Medicare fee schedule.
Summary: The committee heard House Bill 66, which would expand and restructure the Health Care Professional Loan Repayment Fund. The sponsor said the substitute narrows the bill to a $25 million fund, with 50% reserved for physicians and the rest for other health professionals, and raises physician awards to at least $75,000 per year for a four-year commitment. Supporters from nursing, physical therapy, health systems, social work, and advocacy groups said the program would help recruit and retain providers in New Mexico. The committee moved the substitute and then passed the bill on a do-pass motion. House Bill 38, dealing with coverage for prosthetics, orthotics, and mobility devices, drew extensive testimony from amputees, Paralympians, clinicians, and disability advocates. The bill would clarify and expand coverage for activity prosthetics, activity wheelchairs, and related complex rehab technology, with limits on the number of devices and replacement tied to physiological changes. Supporters said access to these devices is medically necessary for physical and mental health, independence, and participation in sports and daily life. After questions about provider qualifications, insurance contracting, and replacement for growing children, the committee adopted the substitute and passed the bill. House Bill 257 would appropriate funds to increase Medicaid reimbursement for vagus nerve stimulation implants for drug-resistant epilepsy. The sponsor and manufacturer’s representative argued current reimbursement is too low, leaving only UNM Hospital performing the procedures and limiting access statewide; they said better reimbursement could reduce emergency visits and long-term Medicaid costs. Members raised concerns about the bill’s language, including whether it could allow payment above allowable rates or create uncertainty about the reimbursement standard. A motion to table failed, and the committee then passed the bill 5-4, with several members noting they supported the concept but wanted the language tightened before the next committee. The committee also passed House Bill 178, which appropriates $3 million for shade structures in rural parks and outdoor recreation areas, after testimony that the project would reduce sun exposure, heat illness, and skin cancer risk. House Bill 198, which provides $2 million for peer-to-peer mental health training and treatment for first responders, also advanced on a do-pass without recommendation after members said they supported the goal but wanted clearer language on training standards, liability, and administration. Finally, House Bill 202, which would require data-sharing agreements to help the Office of Child Advocate access records from state agencies, drew support from child advocacy groups but concern from IT and family advocates about timelines, system complexity, privacy, and the need for family collaboration; the discussion continued with suggestions to refine the bill.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Mental Health, Substance Use and Recovery Jun 21st, 2026 at 11:00 am

Joint Committee on Mental Health, Substance Use and Recovery

Transcript Highlights:
  • use versus reducing drug use versus promoting drug use or preventing drug use.
  • So OPCs don't necessarily increase drug use or attract drug users, but it is a place to deal with drug
  • drug testing.
  • drug testing.
  • On the issue of liability, it is generally a crime to be in the presence of scheduled drugs or narcotics
Keywords: 995, all
Summary: The Joint Committee on Mental Health, Substance Use, and Recovery held a public hearing on several harm reduction bills, including measures to decriminalize simple possession and paraphernalia, authorize overdose prevention centers, and expand access to naloxone for first responders. Chair Mindy Domb and Senator John Velis opened by describing harm reduction as an evidence-based public health strategy and noting Massachusetts’ recent decline in fatal overdoses. They emphasized that testimony would help shape whether and how the bills advance, and explained the hearing process, including time limits and written testimony. Testimony was sharply divided. Supporters, including Rep. Kate Donaghue, Sen. Cindy Friedman, Rep. Marjorie Decker, Rep. Manny Cruz, public health professionals, recovery advocates, and people with lived experience, argued that harm reduction saves lives, reduces stigma, and can connect people to treatment. They supported overdose prevention centers and decriminalization as tools to keep people alive long enough to enter recovery, and several speakers described personal losses to overdose or family experiences with addiction. Some supporters also framed the bills as racial justice measures, arguing that criminal penalties for possession have disproportionately harmed Black and brown communities. Opponents, including Sen. Nick Collins and several South End residents, argued that overdose prevention centers and decriminalization would worsen public drug use, crime, and neighborhood disorder, especially around Mass and Cass. They said current approaches such as Section 35, diversion, and police leverage into treatment are more effective, and they urged more treatment beds and recovery facilities instead of harm reduction sites. Committee members questioned witnesses about research, local siting, crime data, and the relationship between harm reduction and treatment, and several members said neighborhood impacts must be considered alongside overdose prevention. The committee did not take a vote during the hearing; it continued receiving testimony and announced a later break before resuming on H. 2196 and S. 1393.
KY
Transcript Highlights:
  • We also use it for drug court.
  • We also use it for drug usually uses. We also use it for drug court<00:24:26.400><c> D.
  • One is make all scheduled court appearances, have no new offenses, no alcohol or drugs.
  • One is make all scheduled court appearances, have no new offenses, no alcohol or drugs.
  • One is make all scheduled court appearances, have no new offenses, no alcohol or drugs.
Summary: The committee first established a quorum, approved the minutes from the November 7, 2024 meeting, and then heard an update on disaster response and courthouse recovery efforts after the April flooding. Representatives from the Administrative Office of the Courts, the Franklin County Circuit and District Court Clerk’s office, and the Franklin Circuit Court described damage in Perry, Hardin, and especially Franklin counties. Perry County had limited roof and water infiltration issues with no operational impact. Hardin County’s justice center basement took about 18 inches of water, affecting court records and mechanical/electrical equipment, and court operations were briefly suspended. Franklin County’s courthouse was far more severely damaged, with about four feet of water on the first floor, forcing relocation of court operations to temporary sites, including AOC space and the regional jail for custody proceedings. Witnesses said damaged files from Hardin and Franklin counties were removed, sent to an out-of-state vendor for drying and remediation, and would be returned or destroyed as appropriate. They estimated combined costs for file restoration, building repair, and remediation at about $11 million, with insurance through KCOJ/KO expected to cover only part of the losses and FEMA reimbursement still pending a federal disaster declaration. They also said the Franklin County courthouse’s first floor remains gutted, electrical panels and HVAC systems need major replacement, and the second and third floors may be used temporarily once power and data are restored. Members asked about roof damage in Hardin County, the status of FEMA applications, digitization of court records, and whether Senate Bill 25 restricted funds could be used to cover the funding gap; staff said the funds cannot be spent without General Assembly authorization. The committee also discussed broader record-retention and e-filing issues, with members noting the limits of paper filing and the need for better digitization as a backup in emergencies. AOC staff said they are working with the Supreme Court and state law librarian on what records can be digitized and how long hard copies must still be retained. After the disaster-response presentation, the committee moved on to a separate informational presentation on pre-trial services, with introductions from the executive officer of pre-trial services, the president of the Kentucky District Judges Association, a circuit judge, and the manager of pre-trial services, who began explaining how the pre-trial system works for newer committee members.
WA

Washington 2025-2026 Regular Session

Senate Human Services Feb 3rd, 2026 at 01:30 pm

Human Services

Transcript Highlights:
  • Thanks for taking the time out of your schedule for joining us. Lieutenant Governor: Thank you.
  • Thanks for taking the time out of your schedule for joining us. Thank you. You're welcome. Dr.
  • Ramirez, thanks for taking the time out of your schedule for joining us. Thank you. You're welcome.
  • drug portion to them, and so this is the one basic thing we can do to start.
  • drug portion to them, and so this is the one basic thing we can do to start making a change in that
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Mental Health, Substance Use and Recovery Jun 21st, 2026 at 01:00 pm

Joint Committee on Mental Health, Substance Use and Recovery

Transcript Highlights:
  • drugs.
  • Of someone actively using drugs.
  • The reason why these drugs were shelved and categorized as Schedule I was because we did have the wild
  • The reason why these drugs were shelved and categorized as Schedule I was because it was, we did have
  • The reason why these drugs were shelved and categorized as Schedule I was because we did have the wild
Keywords: 995, all
Summary: The Joint Committee on Mental Health, Substance Use and Recovery opened its first public hearing of the 2025–26 session with remarks from the Senate and House chairs outlining the committee’s priorities. They noted recent work on addiction and recovery legislation, the ongoing youth behavioral health crisis, and that members might need to leave periodically for floor votes. The chairs explained hearing procedures, including three-minute testimony limits, written testimony deadlines, and reporting deadlines for Senate and House bills. The hearing then focused on several bills related to youth mental health, overdose prevention, and psychedelic treatment research. A major portion of the hearing centered on bills to improve youth crisis response and overdose prevention. Testimony strongly supported bills to print the 988 Suicide and Crisis Lifeline on student ID cards, with speakers from mental health organizations, crisis centers, and individuals sharing personal stories of depression, suicide attempts, and the importance of making 988 as familiar as 911. Another set of bills would require schools to stock naloxone and provide overdose prevention education. Physicians, harm reduction advocates, students, and grieving family members testified that school-based Narcan access and education could save lives, reduce stigma, and help students recognize overdoses and understand Good Samaritan protections. Senator O’Connor and Tamika Perry also testified for a bill to strengthen substance use prevention education and reduce overdose abandonment, emphasizing the need to teach students about overdose risks and the legal protections for calling 911. The committee also heard testimony on a bill to authorize a pilot program for psychedelic treatment in licensed facilities. Senator Friedman and several medical and behavioral health professionals argued the proposal was a narrow, research-based approach distinct from the broader ballot question rejected in 2024. They said the bill would allow only a small number of supervised clinics to use psychedelics for conditions such as depression, PTSD, anxiety, and substance use disorders, with data reporting and Department of Public Health oversight. Supporters described it as a cautious way to study promising treatments while avoiding unsupervised or commercialized use. Finally, the committee heard support for a bill to create a special commission and five-year strategic plan for children’s behavioral health services, with testimony that the current system is fragmented, difficult for families to navigate, and strained by workforce and funding challenges. No votes or final actions were taken during the hearing; the committee primarily received testimony and questions on the bills.
WA

Washington 2025-2026 Regular Session

House Health Care & Wellness Feb 18th, 2026 at 01:30 pm

Health Care & Wellness

Transcript Highlights:
  • Like there's a payment schedule that carriers should follow, and a lot of times they're denying claims
  • Now the stockpile of unused drugs is about to expire.
  • bulk distribution of the drugs to unnamed and unknown appropriate recipients.
  • Millions of taxpayer dollars were wasted on drugs meant to kill babies and not enough demand.
  • Since the bill provides for free distribution of the drug, it is probably unconstitutional.
Bills: SB5915 , SB5988 , SB6025 , SJM8002
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Public Health Jun 21st, 2026 at 10:00 am

Joint Committee on Public Health

Transcript Highlights:
  • . ...wasn't reporting a rape or a sexual assault, they wouldn't test her for the drug, for any drugs.
  • , drug-facilitated sexual assaults.
  • She begged for a drug test multiple times, but he refused.
  • Classifying psilocybin as Schedule I is fraudulent.
  • Classifying psilocybin as Schedule I is fraudulent.
Keywords: 995, all
Summary: The committee heard testimony on a wide range of public health and emergency services bills, with many speakers focusing on EMS system failures, hospital service closures, trauma preparedness, epilepsy awareness, drink-spiking response, sudden cardiac arrest, and survivor financial assistance. Several legislators and advocates described the EMS system as underfunded and overstretched, citing long ambulance waits, staffing shortages, and the need for statewide oversight, a special commission, and clearer recognition of EMS as an essential service. A number of speakers also supported bills to preserve essential hospital services after closures such as Nashoba Valley Medical Center and birthing services in Leominster, arguing that current closure rules lack enforcement and leave communities without critical care. Multiple panels testified in support of bills requiring trauma kits in public buildings, public education on SUDEP and epilepsy mortality, and improved cardiac arrest response. Supporters of the trauma-kit bill said public buildings should have bleeding-control kits and trained staff, comparing them to AEDs and first aid supplies. Epilepsy advocates, clinicians, and grieving parents urged a public health campaign on SUDEP, saying families are often not warned about the risk and that awareness could improve medication adherence, reduce guilt, and save lives. On cardiac arrest, EMS professionals and the American Heart Association backed measures to improve telecommunicator CPR, create an AED registry, and strengthen dispatch and training standards. The committee also heard extensive testimony on a bill addressing illicit drink spiking. Senators, city officials, victims, physicians, and an international anti-spiking advocate described cases in which hospitals refused toxicology testing unless a sexual assault was reported, and argued for standardized testing protocols, better data collection, and coordination with law enforcement and licensed venues. Another bill drew a sharp exchange over local public health control and the SAFE 2.0 law, with one senator arguing for more local approval and voluntary participation, while committee members defended the earlier law as a response to inequities in local public health capacity. Finally, advocates from Jane Doe, Inc. supported legislation to provide flexible financial assistance to survivors of domestic and sexual violence, saying unrestricted cash helps survivors meet basic needs, escape abuse, and rebuild stability.
WA

Washington 2025-2026 Regular Session

Senate Health & Long-Term Care Feb 19th, 2026

Transcript Highlights:
  • So it didn't have the opportunity to give five days to schedule.
  • So a lot of this is not drug seeking.
  • So a lot of this is not drug-seeking.
  • Requiring an in-person examination to prescribe drugs or to perform regulatory work.
  • human drugs, or the use of FDA-approved animal drugs used extra label, which means they're used in a
Summary: The Senate Health and Long-Term Care Committee held public hearings on several House bills and later took executive action on two others. The committee heard testimony on House Bill 2242, which would let the Department of Health issue immunization recommendations and tie preventive-service coverage to federal recommendations as of June 30, 2025, while preserving access to vaccines and other preventive services. Supporters, including the Governor’s office and the Insurance Commissioner, said the bill would protect access, affordability, and stable vaccine purchasing; opponents argued it politicizes vaccine policy and gives too much influence to state agencies and outside groups. The committee also heard testimony on House Bill 2152, allowing terminally ill patients in hospitals, nursing homes, and hospice facilities to use medical cannabis under facility policies, with supporters emphasizing dignity, symptom relief, and safeguards, and House Bill 2088, joining the dietitian licensure compact, which supporters said would help military spouses, telehealth, and workforce shortages. House Bill 2110, on ambulance inter-facility specialty care transports, drew support from rural hospitals seeking more staffing flexibility and opposition from nurses and EMS personnel concerned about training, accountability, and patient safety. House Bill 2247, on veterinarian-client-patient relationships and telemedicine, drew support from the sponsor and some stakeholders as a workforce and access measure, but also criticism from the state veterinarian and others who said it could conflict with federal VCPR requirements and public health protections. House Bill 2340, expanding substance use disorder monitoring program eligibility to nursing assistants and stipend support, was presented as a way to help low-wage health workers stay in the workforce; there were no in-person testifiers against it. In executive session, the committee considered House Bill 2155, concerning the use of nursing titles, and House Bill 2531, aligning the ambulance transport fund quality assurance fee with federal regulations. Both bills received do-pass recommendations and were sent to the Rules Committee. For the public hearings, no final committee votes were taken on the other bills in this transcript, and testimony concluded on each measure after the committee heard from sponsors, agency officials, advocates, and opponents.